Ginkgo Bioworks Holdings Inc (DNA) is around the middle of the Biotechnology industry according to InvestorsObserver. DNA received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Ginkgo Bioworks Holdings Inc also achieved a score of 36 in the Biotechnology industry, putting it above 36 percent of Biotechnology stocks. Biotechnology is ranked 41 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What’s Happening With Ginkgo Bioworks Holdings Inc Stock Today?
Ginkgo Bioworks Holdings Inc (DNA) stock is higher by 0.89% while the S&P 500 is down -0.16% as of 10:01 AM on Tuesday, Jan 3. DNA is up $0.01 from the previous closing price of $1.69 on volume of 2,267,904 shares. Over the past year the S&P 500 is lower by -20.08% while DNA is down -80.32%. DNA lost -$2.23 per share the over the last 12 months. Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.
